1.
Drug Discov Today
; 21(2): 212-6, 2016 Feb.
Artículo
en Inglés
| MEDLINE
| ID: mdl-26523771
RESUMEN
Billions of dollars spent, millions of subject-hours of clinical trial experience and an abundance of archived study-level data, yet why are historical data underutilized? We propose that historical data can be aggregated to provide safety, background incidence rate and context to improve the evaluation of new medicinal products. Here, we describe the development and application of the eControls database, which is derived from the control arms of studies of licensed products, and discuss the challenges and potential solutions to the proper application of historical data to help interpret product safety.